Back

Arcutis Biotherapeutics Quote, Financials, Valuation and Earnings

7 Stocks to Own Before the 2024 Election

Click the link below to get your copy. FREE

Buy

ARQT
Arcutis Biotherapeutics

Last Price:

9.61

Seasonality Move:

-17.15%

7 Day Trial

ALL ACCESS PASS

$ 7

What's Nvidia doing next??

Click here now to learn more about Nvidia's next AI move.

Arcutis Biotherapeutics Price Quote

$9.61

+0.01 (+3.33%)

(Updated: July 4, 2024 at 4:40 AM ET)

Arcutis Biotherapeutics Key Stats

Buy

Arcutis Biotherapeutics (ARQT) is a Buy

Day range:

$9.31 - $9.90

52-week range:

$1.76 - $13.17

Dividend yield:

P/E ratio:

0.00

P/S ratio:

7.38

P/B ratio:

4.94%

Volume:

1.6M

Avg. volume:

2.8M

1-year change:

9.71%

Market cap:

$1.1B

Revenue:

$59.6M

EPS:

$-2.93

How Much Does Arcutis Biotherapeutics Make?

How Much Are Arcutis Biotherapeutics's Sales Annually?
ARQT Revenues are $59.6M
How Much Profit Does Arcutis Biotherapeutics's Make A Year?
ARQT net income is -$262.1M

Is Arcutis Biotherapeutics Growing As A Company?

What Is Arcutis Biotherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 16.82%
What Is Arcutis Biotherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Arcutis Biotherapeutics Stock Price Performance

Did Arcutis Biotherapeutics Stock Go Up Last Month?
Arcutis Biotherapeutics share price went up by 17.5% last month
Did ARQT's Share Price Rise Over The Last Year?
ARQT share price rose by 9.71% over the past 1 year

What Is Arcutis Biotherapeutics 52-Week High & Low?

What Is Arcutis Biotherapeutics’s 52-Week High Share Price?
Arcutis Biotherapeutics has traded as high as $13.17 over the past 52 weeks
What Is Arcutis Biotherapeutics’s 52-Week Low Share Price?
Arcutis Biotherapeutics has traded as low as $1.76 over the past 52 weeks

Arcutis Biotherapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arcutis Biotherapeutics?

How Much Debt Does Arcutis Biotherapeutics Have?
Total long term debt quarterly is $202.8M
How Much Cash Does Arcutis Biotherapeutics Have?
Cash and short term investments quarterly total is $403.9M
What Is Arcutis Biotherapeutics’s Book Value Per Share?
Book value per share is 1.95

Is Arcutis Biotherapeutics Cash Flow Positive?

What Is ARQT Cash Flow From Operations?
Cash flow from operations (TTM) is -$198.3M
What Is Arcutis Biotherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $263M
What Is Arcutis Biotherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $43.8M

Arcutis Biotherapeutics Return On Invested Capital

Is Management Doing A Good Job?
ARQT return on invested capital is -68.61%
What Is Arcutis Biotherapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -59.96%
What Is ARQT Return On Equity?
ROE is a measure of profitability and is -187.25%

Arcutis Biotherapeutics Earnings Date & Stock Price

What Is Arcutis Biotherapeutics's Stock Price Today?
A single share of ARQT can be purchased today for 9.60
What Is Arcutis Biotherapeutics’s Stock Symbol?
Arcutis Biotherapeutics trades on the nasdaq under the ticker symbol: ARQT
When Is Arcutis Biotherapeutics’s Next Earnings Date?
The next quarterly earnings date for Arcutis Biotherapeutics is scheduled on August 8, 2024
When Is ARQT's next ex-dividend date?
Arcutis Biotherapeutics's next ex-dividend date is July 4, 2024
How To Buy Arcutis Biotherapeutics Stock?
You can buy Arcutis Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Arcutis Biotherapeutics Competitors

Who Are Arcutis Biotherapeutics's Competitors?
Below is a list of companies who compete with Arcutis Biotherapeutics or are related in some way:
- Agios Pharmaceuticals Inc (AGIO)
- Amgen Inc (AMGN)
- Heron Therapeutics Inc (HRTX)
- Marinus Pharmaceuticals Inc (MRNS)
- Pfizer Inc (PFE)

Arcutis Biotherapeutics Dividend Yield